$LUDG to announce that the company is planning to
Post# of 40255
Thanks to Precision Genomics' success, a wholly owned subsidiary of Ludwig, in featuring Marvin S. Hausman, MD, at the LD Micro Conference, Los Angeles, CA last month, the company has attracted strong interest and has received terms from several investment banks and family offices. In addition, the company is confident it will complete a bridge financing round of $1 million (One million dollars), with $500k already raised in a family and friends' round. The company is targeting the IPO (S1) launch in Q1 of 2023.